Involvement of adenosine A(2A) receptors in the induction of c-fos expression by clozapine and haloperidol

Neuropsychopharmacology

Volumn 20, Issue 1, 1999, Pages 44-51

  Pinna, Annalisa ^b   Wardas, Jadwiga ^a   Cozzolino, Alberto ^b   Morelli, Micaela ^b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b NONE

Author keywords

Adenosine A(2A) receptor; Antipsychotic; Clozapine; Early genes; Fos like immunoreactivity; Haloperidol

Indexed keywords

5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; ADENOSINE A2A RECEPTOR; CLOZAPINE; HALOPERIDOL; ADENOSINE RECEPTOR; NEUROLEPTIC AGENT; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; GENE EXPRESSION REGULATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROPHARMACOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; ONCOGENE C FOS; PRIORITY JOURNAL; PSYCHOSIS; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; DRUG ANTAGONISM; GENE EXPRESSION; METABOLISM; NERVE CELL; ONCOGENE; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; GENE EXPRESSION; GENES, FOS; HALOPERIDOL; MALE; NEURONS; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A; RECEPTORS, PURINERGIC P1; TRIAZOLES;

EID: 0032589811     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(98)00051-7     Document Type: Article

References (37)

1. 2A receptors in the nucleus accumbens mediate locomotor depression. Brian Res Bull. 31:1993;397-404.
2. Boegman R.J., Vincent S.R. Involvement of adenosine and glutamate receptors in the induction of c-fos in the striatum by haloperidol. Synapse. 22:1996;70-77.
3. Brunello N., Masotto C., Steardo L., Markstein R., Racagni G. New insights into the biology of schizophrenia through the mechanism of action of clozapine. Neuropsychopharmacology. 13:1995;177-212.
4. Carta A., Gerfen C. Clozapine induction of c-fos in D3 deficient mice. A double labeling in situ hybridization study Abstr Neurosci Soc. 505:1997;1282.
5. Deutch A.Y., Duman R.S. The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex. Cellular localization and pharmacological characterization Neuroscience. 70:1996;377-389.
6. Deutch A.Y., Lee M., Iadarola M.J. Regionally specific effects of atypical antipsychotic drugs on striatal FOS expression. The nucleus accumbens shell as a locus of antipsychotic action Mol Cell Neurosci. 3:1992;332-341.
7. 2 receptors in the neostriatum. Brain Res. 594:1992;124-130.
8. 2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia. Neuroscience. 63:1994;765-773.
9. Ferré S., Fredholm B.B., Morelli M., Popoli P., Fuxe K. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci. 20:1997;482-487.
10. Fibiger H.C. Neuroanatomical targets of neuroleptic drugs as revealed by Fos immunochemistry. J Clin Psychiatr. 55:1994;33-36.
11. 2 dopamine receptors in rat striatum Mol Brain Res. 14:1992;186-195.
12. Guo N., Klitenick M.A., Tham C.-S., Fibiger H.C. Receptor mechanisms mediating clozapine-induced c-fos expression in the forebrain. Neuroscience. 65:1995;747-753.
13. 2A receptors in the nucleus accumbens modulate prepulse inhibition of the startle response. NeuroReport. 8:1997;1515-1518.
14. Heffner T.G., Wiley J.N., Williams A.E., Bruns R.F., Coughenour L.L., Downs D.A. Comparison of the behavioral effects of adenosine agonists and dopamine antagonists in mice. Psychopharmacology. 98:1989;31-37.
15. 3H]CGS 21680. Eur J Pharmacol. 168:1989;243-246.
16. 2 receptor interaction in animal models of schizophrenia. Eur J Pharmacol. 295:1996;147-154.
17. MacGibbon G.A., Lawlor P.A., Bravo R., Dragunow M. Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja. Mol Brain Res. 23:1994;21-32.
18. Martin G.E., Rossi D.J., Jarvis M.F. Adenosine agonists reduce conditioned avoidance responding in the rat. Pharmacol Biochem Behav. 45:1993;951-958.
19. 3 receptors Cereb Cortex. 6:1996;561-570.
20. 2a adenosine receptor agonist 2-hexynyl-5′-N-ethylcarboxamidoadenosine. Arzneim-Forsch/Drug Res. 44:1994;1296-1304.
21. Morgan J.J., Curran T. Proto-oncogene transcription factors and epilepsy. Trends Pharmacol Sci. 12:1991;343-345.
22. 2 receptors in unilaterally 6-hydroxydopamine lesioned rats. Eur J Pharmacol. 251:1994;21-25.
23. Nguyen T.V., Kosofsky B.E., Birnbaum R., Cohen B.M., Hyman S.E. Differential expression of c-fos and Zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc Natl Acad Sci USA. 89:1992;4270-4274.
24. 2A receptors in rat striatum. Implications for the mechanism and the treatment of tardive dyskinesia J Neurochem. 65:1995;2057-2064.
25. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 2:1986;Academic Press, London.
26. 1 agonists in dopamine denervated rats. Eur J Neurosci. 8:1996;1176-1181.
27. 2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas. Brain Res. 759:1997;41-49.
28. Popoli P., Pezzolla A., Reggio R., Caporali M.G., Scotti De Carolis A. CGS 21680 antagonizes motor hyperactivity in a rat model of Hungtngton's disease. Eur J Pharmacol. 257:1994;R5-R6.
29. 2A agonists. A potential new type of atypical antipsychotic Neuropsychopharmacology. 17:1997;82-91.
30. Robertson G.S., Fibiger H. Neuroleptics increase c-fos expression in the forebrain. Contrasting effects of haloperidol and clozapine Neuroscience. 46:1992;315-328.
31. Robertson G.S., Matsumura H., Fibiger H.C. Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J Pharmacol Exp Therapeu. 271:1994;1058-1066.
32. 2A receptors regulate the gene expression of striatopallidal and striatonigral neurons. J Neurosci. 13:1993;1080-1087.
33. 2 receptor-mediated excitatory actions on the nervous system. Prog Neurobiol. 48:1996;167-189.
34. 2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas. Neuroscience. 80:1997;1171-1185.
35. Vahid-Ansari F., Robertson G.S. 7-OH-DPAT Differentially reverse clozapine- and haloperidol-induced increases in Fos-like immunoreactivity in the rodent forebrain. Eur J Neurosci. 8:1996;2605-2611.
36. 2A receptor regulation of apomorphine-induced turning in rats with unilateral striatal dopamine denervation. Psychopharmacology. 111:1993;383-388.
37. 2A adenosine receptor antagonist. J Pharmacol Exp Ther. 276:1996;389-404.